Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism RXRs agonists(Retinoid X receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | Germany | 24 Jul 2025 | |
| Metabolic Diseases | Preclinical | Germany | 24 Jul 2025 | |
| Neoplasms | Preclinical | Germany | 24 Jul 2025 | |
| Neurodegenerative Diseases | Preclinical | Germany | 24 Jul 2025 |





